Enterprise Products Partners L.P. (NYSE:EPD) shares advanced 0.04% in last trading session and ended the day at $24.31. EPD Gross Margin is 12.40% and its has a return on assets of 5.20%. Enterprise Products Partners L.P. (NYSE:EPD) quarterly performance is -6.32%.
Enterprise Products Partners L.P. (NYSE:EPD) said that, Braskem SA signed a 10-year contract with U.S.-based Enterprise Products Partners LP for the supply of ethane imported from the United States.
Investment Technology Group, Inc. (NYSE:ITG) ended the last trading day at $21.68. Company weekly volatility is calculated as 3.35% and price to cash ratio as 2.15. Investment Technology Group, Inc. (NYSE:ITG) showed a weekly performance of 0.23%.
Investment Technology Group (NYSE:ITG) had its target price increased by research analysts at Credit Suisse from $24.00 to $26.00 in a research note issued on Tuesday, StockTargetPrices.com reports. The firm currently has an “outperform” rating on the stock. Credit Suisse’s target price points to a potential upside of 25.97% from the stock’s previous close.
ArcelorMittal SA (ADR) (NYSE:MT) ended the last trading day at $4.36. Company weekly volatility is calculated as 5.45% and price to cash ratio as 3.21. ArcelorMittal SA (ADR) (NYSE:MT) showed a weekly performance of -0.68%.
On 15 March, ArcelorMittal SA (ADR) (NYSE:MT) is raising $3 billion from investors to cut debt by selling new stock for $2.44 a share. The Luxembourg-based steelmaker, the largest in the world in production, is offering shareholders seven new shares for every 10 they own at a 35 percent discount.
CombiMatrix Corporation (NASDAQ:CBMX) shares moved down -1.04% in last trading session and ended the day at $3.80. CBMX Gross Margin is 46.50% and its has a return on assets of -75.30%. CombiMatrix Corporation (NASDAQ:CBMX) quarterly performance is -69.11%.
CombiMatrix Corporation (NASDAQ:CBMX) announces that global health provider Cigna Health Services, Blue Cross Blue Shield of North Carolina, Premera Blue Cross Blue Shield and Life Wise of Oregon, an affiliate of Premera, have all revised their medical policies to include chromosomal microarray testing as medically necessary for the evaluation of recurrent pregnancy loss (i.e., two or more consecutive pregnancy losses). Since the beginning of 2016, six health plans have revised their medical policies to include coverage of recurrent pregnancy testing.
Fortuna Silver Mines Inc. (NYSE:FSM) caters to the Basic Materials space. On the last day of trading company shares ended up at $4.00. Fortuna Silver Mines Inc. (NYSE:FSM) distance from 50-day simple moving average (SMA50) is 22.50%.
Fortuna Silver Mines Inc. (NYSE:FSM) announces that it has filed today its 2015 annual report on Form 40-F with the U.S. Securities and Exchange Commission (‘SEC’). The Form 40-F, which includes the company’s fiscal 2015 annual audited financial statements, management’s discussion and analysis and annual information form, is available on Fortuna’s website
Leave a Reply